Clinical Trial Update: Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

View source ↗

Summary

This document reports the completion and posting of results from a trial evaluating telmisartan's effect on blood pressure and cardiovascular risk factors in hi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hypertension

Drugs mentioned

• Telmisartan (Micardis) (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Cardiovascular Diseases | Status: COMPLETED | Results posted: 2012-08-21